Follow the 에스티팜 stock price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 에스티팜 has logged 8 insider filings. Market capitalisation: €2,542.3bn. The latest transaction was filed on 30 April 2026 (Purchase). Among the most active insiders: 동아쏘시오홀딩스. The full history is free.
Analysts rate 에스티팜 Strong Buy (bullish), based on 10 analysts. Average price target: ₩197,000.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
8 of 8 declarations